PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.\', \'Division of Rheumatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.\', \'Immune Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.\', \'Center for Neuroinflammation and Experimental Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.\', \'Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.\', \'Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.\', \'Immunology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.\', \'Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.\', \'Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.\', \'Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA.\', \'Penn Center for Research on Coronavirus and Other Emerging Pathogens, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.\', \'Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.\', \'Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. wherry@pennmedicine.upenn.edu.\', \'Immune Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. wherry@pennmedicine.upenn.edu.\', \'Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. wherry@pennmedicine.upenn.edu.\', \'Parker Institute for Cancer Immunotherapy, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. wherry@pennmedicine.upenn.edu.\', \'Center for Neuroinflammation and Experimental Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. lirui158@pennmedicine.upenn.edu.\', \'Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. lirui158@pennmedicine.upenn.edu.\', \'Center for Neuroinflammation and Experimental Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. amitbar@pennmedicine.upenn.edu.\', \'Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. amitbar@pennmedicine.upenn.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41591-021-01507-2
?:hasPublicationType
?:journal
  • Nature medicine
is ?:pmid of
?:pmid
?:pmid
  • 34522051
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 17.067
?:rankingScore_hIndex
  • 484
is ?:relation_isRelatedTo_publication of
?:title
  • Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all